Literature DB >> 16133357

STAT 5a expression in various lesions of the breast.

Gary L Bratthauer1, Brian L Strauss, Fattaneh A Tavassoli.   

Abstract

The seven signal transducer and activator of transcription (STAT) molecules are effectors of hormonal or cytokine stimulation through receptors. STAT 5a, isolated from prolactin-stimulated mammary cells, contributes to normal proliferation and is essential for mammary gland differentiation. Using a monoclonal antibody, we tested 100 formalin-fixed, paraffin-embedded breast tissues representing everything from simple hyperplasia to invasive carcinoma for the expression of STAT 5a in comparison to normal breast epithelial cells. Immunohistochemical analysis was performed following heat treatment in a pressure cooker. STAT 5a was found in endothelial cells, adipocytes, and leukocytes as well as in the cytoplasm and nucleus of normal epithelial cells, usual ductal hyperplasia, and benign lesions such as fibroadenoma. Myoepithelial cells and stromal fibroblasts failed to demonstrate any STAT 5a in addition to most atypical proliferations including in situ and invasive carcinomas. A few examples of lobular intraepithelial neoplasia and invasive carcinoma demonstrated some reactivity, albeit comparatively reduced. The absence of STAT 5a in the abnormal breast epithelial cells may indicate a defect contributory to the abnormal state.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16133357     DOI: 10.1007/s00428-005-0056-6

Source DB:  PubMed          Journal:  Virchows Arch        ISSN: 0945-6317            Impact factor:   4.064


  29 in total

Review 1.  Functional roles of STAT family proteins: lessons from knockout mice.

Authors:  S Akira
Journal:  Stem Cells       Date:  1999       Impact factor: 6.277

2.  SOCS-1, -2, -3: selective targets and functions downstream of the prolactin receptor.

Authors:  S Tomic; N Chughtai; S Ali
Journal:  Mol Cell Endocrinol       Date:  1999-12-20       Impact factor: 4.102

3.  Breast pathology: rationale for adopting the ductal intraepithelial neoplasia (DIN) classification.

Authors:  Fattaneh A Tavassoli
Journal:  Nat Clin Pract Oncol       Date:  2005-03

4.  Platelet-derived growth factor (PDGF)-induced activation of signal transducer and activator of transcription (Stat) 5 is mediated by PDGF beta-receptor and is not dependent on c-src, fyn, jak1 or jak2 kinases.

Authors:  K Paukku; S Valgeirsdóttir; P Saharinen; M Bergman; C H Heldin; O Silvennoinen
Journal:  Biochem J       Date:  2000-02-01       Impact factor: 3.857

5.  Basal activation of transcription factor signal transducer and activator of transcription (Stat5) in nonpregnant mouse and human breast epithelium.

Authors:  Marja T Nevalainen; Jianwu Xie; Lukas Bubendorf; Kay-Uwe Wagner; Hallgeir Rui
Journal:  Mol Endocrinol       Date:  2002-05

6.  Possible role of Stat5a in rat mammary gland carcinogenesis.

Authors:  Liang Shan; Minshu Yu; Bradly D Clark; Elizabeth G Snyderwine
Journal:  Breast Cancer Res Treat       Date:  2004-12       Impact factor: 4.872

7.  Tissue-specific induction of SOCS gene expression by PRL.

Authors:  S P Tam; P Lau; J Djiane; D J Hilton; M J Waters
Journal:  Endocrinology       Date:  2001-11       Impact factor: 4.736

8.  Deregulation of Stat5 expression and activation causes mammary tumors in transgenic mice.

Authors:  Elena Iavnilovitch; Robert D Cardiff; Bernd Groner; Itamar Barash
Journal:  Int J Cancer       Date:  2004-11-20       Impact factor: 7.396

Review 9.  Interleukin-3, granulocyte-macrophage colony-stimulating factor, and interleukin-5 transduce signals through two forms of STAT5.

Authors:  A L Mui; H Wakao; N Harada; A M O'Farrell; A Miyajima
Journal:  J Leukoc Biol       Date:  1995-05       Impact factor: 4.962

10.  Signal transducer and activator of transcription-5 activation and breast cancer prognosis.

Authors:  Marja T Nevalainen; Jianwu Xie; Joachim Torhorst; Lukas Bubendorf; Philippe Haas; Juha Kononen; Guido Sauter; Hallgeir Rui
Journal:  J Clin Oncol       Date:  2004-06-01       Impact factor: 44.544

View more
  13 in total

1.  Loss of nuclear localized and tyrosine phosphorylated Stat5 in breast cancer predicts poor clinical outcome and increased risk of antiestrogen therapy failure.

Authors:  Amy R Peck; Agnieszka K Witkiewicz; Chengbao Liu; Ginger A Stringer; Alexander C Klimowicz; Edward Pequignot; Boris Freydin; Thai H Tran; Ning Yang; Anne L Rosenberg; Jeffrey A Hooke; Albert J Kovatich; Marja T Nevalainen; Craig D Shriver; Terry Hyslop; Guido Sauter; David L Rimm; Anthony M Magliocco; Hallgeir Rui
Journal:  J Clin Oncol       Date:  2011-05-16       Impact factor: 44.544

2.  PTP1B suppresses prolactin activation of Stat5 in breast cancer cells.

Authors:  Kevin J Johnson; Amy R Peck; Chengbao Liu; Thai H Tran; Fransiscus E Utama; Ashley B Sjolund; John D Schaber; Agnieszka K Witkiewicz; Hallgeir Rui
Journal:  Am J Pathol       Date:  2010-10-15       Impact factor: 4.307

3.  Higher expression levels of SOCS 1,3,4,7 are associated with earlier tumour stage and better clinical outcome in human breast cancer.

Authors:  Walid Sasi; Wen G Jiang; Anup Sharma; Kefah Mokbel
Journal:  BMC Cancer       Date:  2010-04-30       Impact factor: 4.430

Review 4.  Signal transducer and activator of transcription 5A/B in prostate and breast cancers.

Authors:  Shyh-Han Tan; Marja T Nevalainen
Journal:  Endocr Relat Cancer       Date:  2008-06       Impact factor: 5.678

Review 5.  Jak2/Stat5 signaling in mammogenesis, breast cancer initiation and progression.

Authors:  Kay-Uwe Wagner; Hallgeir Rui
Journal:  J Mammary Gland Biol Neoplasia       Date:  2008-01-29       Impact factor: 2.673

6.  Complex prolactin crosstalk in breast cancer: new therapeutic implications.

Authors:  Kristopher C Carver; Lisa M Arendt; Linda A Schuler
Journal:  Mol Cell Endocrinol       Date:  2009-04-01       Impact factor: 4.102

7.  Cell-type-specific expression of STAT transcription factors in tissue samples from patients with lymphocytic thyroiditis.

Authors:  Julia Staab; Peter J Barth; Thomas Meyer
Journal:  Endocr Pathol       Date:  2012-09       Impact factor: 3.943

8.  Reversed Expression of the JAK/STAT Pathway Related Proteins Prolactin Receptor and STAT5a in Normal and Abnormal Breast Epithelial Cells.

Authors:  Gary L Bratthauer; Brian L Strauss; Ross Barner
Journal:  Breast Cancer (Auckl)       Date:  2008-02-26

9.  Favorable prognostic value of SOCS2 and IGF-I in breast cancer.

Authors:  Michael C Haffner; Barbara Petridou; Jean Phillipe Peyrat; Françoise Révillion; Elisabeth Müller-Holzner; Günter Daxenbichler; Christian Marth; Wolfgang Doppler
Journal:  BMC Cancer       Date:  2007-07-25       Impact factor: 4.430

10.  Low levels of Stat5a protein in breast cancer are associated with tumor progression and unfavorable clinical outcomes.

Authors:  Amy R Peck; Agnieszka K Witkiewicz; Chengbao Liu; Alexander C Klimowicz; Ginger A Stringer; Edward Pequignot; Boris Freydin; Ning Yang; Adam Ertel; Thai H Tran; Melanie A Girondo; Anne L Rosenberg; Jeffrey A Hooke; Albert J Kovatich; Craig D Shriver; David L Rimm; Anthony M Magliocco; Terry Hyslop; Hallgeir Rui
Journal:  Breast Cancer Res       Date:  2012-10-04       Impact factor: 6.466

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.